This is a completion notice, not a fresh financing surprise. The underwriting agreement and final prospectus supplement were both dated August 11, 2026, so the market already knew the offering’s size and structure before the August 14 closing. The filing mainly confirms that the transaction settled.
| Financing term | Filing detail |
|---|---|
| Principal issued | $90 million (Offering terms) |
| Coupon | 9.600% annually (Offering terms) |
| Issue price | 100% of principal (Offering terms) |
| Maturity | October 1, 2031 (Offering terms) |
| Net proceeds | Approximately $86.6 million (Use of proceeds) |
| Over-allotment option | Up to $13.5 million (Underwriting Agreement) |
The important economic signal is continued access to unsecured funding, but at a high rate. The new notes rank equally with the company’s existing unsecured notes, including securities carrying coupons of 9.125%, 9.125%, 9.875% and 9.250%, so this is not unusually cheap capital for Adamas Trust—but neither is it a low-cost refinancing. 〔0〕
The proceeds add flexibility, not a disclosed earnings catalyst. Management says the approximately $86.6 million of net proceeds may fund targeted asset acquisitions and/or repay existing indebtedness, but the filing does not identify a specific acquisition, repayment, leverage reduction or return to shareholders. 〔1〕
Net read: in line and largely priced in. There is no clean earnings-style beat or miss here; the transaction was already announced and the filing confirms execution on the disclosed terms. The positive element is funding availability, while the offset is a 9.6% fixed coupon and no immediate evidence that the capital will improve returns or reduce leverage.
Read the original 8-K on SEC EDGAR ↗